A Pakistani patient has received a stem cell transplant at a Shanghai hospital, authorities said on Thursday.
"The procedure was a success, and the cure rate will grow by 60 per cent compared to traditional therapies," said Wang Chun, doctor in charge of Tahseen Dilbar's treatment.
Wang said the 30-year-old patient's hematopoietic functions would begin again in two weeks after the transplant.
The cells were donated by a woman who gave birth in Shanghai in 2010.
Tahseen was diagnosed with myelodysplastic syndromes(MDS) in 2010 and had been relying on blood transfusions since then. He came to China in March seeking better treatment.
Patients with MDS have problems making new blood cells and a high risk of developing myeloid leukemia, said Wang.
The patient has also been given peripheral blood stem cells donated by his brother.
According to Wang, cord blood combined with peripheral blood stem cells can reduce the risk of rejection.
China has umbilical cord blood stem cell banks in Beijing, Tianjin, Shanghai, Guangdong and other places.
--IANS
ksk/bg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
